Skip to main content
. 2022 Jan 3;39(2):1068–1080. doi: 10.1007/s12325-021-01981-7

Fig. 2.

Fig. 2

Patient Benefit Index for Skin Diseases (REF): the 10 treatment goals most commonly identified as “very important” at apremilast initiation (PNQ) and the percentage of patients reporting benefit on these goals at month 6 (PBQ). Data are expressed as percentages. PBQ Patient Benefit Questionnaire, PNQ Patient Needs Questionnaire, REF reference analysis set